Press "Enter" to skip to content

Zydus Cadila gets USFDA nod for low blood pressure drug

Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Droxidopa capsules in the strength of 100 mg, 200 mg, and 300 mg, Cadila Healthcare said in a regulatory filing.

Original source: https://health.economictimes.indiatimes.com/news/pharma/81105906?utm_source=RSS&utm_medium=ETRSS

Also Read:   Tata in talks to launch Moderna vaccine in India